Nonpuerperal breast abscess caused by Finegoldia magna;Absceso mamario no puerperal por Finegoldia magna

Revista Argentina de Microbiologia

Volumn 39, Issue 2, 2007, Pages 95-98

  Castello, L ^a   Bou, M ^a   Bazzana, M S ^a   Predari, S C ^a  

^a INSTITUTO DE INVESTIGACIONES MÉDICAS ALFREDO LANARI   (Argentina)

Author keywords

Anaerobic gram positive cocci; Breast abscess; Finegoldia magna

Indexed keywords

AZITHROMYCIN; CEFALOTIN; CLARITHROMYCIN; METRONIDAZOLE; MINOCYCLINE; PENICILLIN G;

ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL FLORA; BACTERIUM CULTURE; BACTERIUM IDENTIFICATION; BACTERIUM ISOLATION; BREAST ABSCESS; HUMAN;

ABSCESS; ADULT; DRUG RESISTANCE, MULTIPLE, BACTERIAL; FEMALE; GRAM-POSITIVE COCCI; HUMANS; MAMMAPLASTY; MASTITIS; POSTOPERATIVE COMPLICATIONS; SPECIES SPECIFICITY;

EID: 34547201454     PISSN: 03257541     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Bourgault AM, Rosenblatt JE, Fitzgerald RH. Peptococcus magnus: a significant human pathogen. Ann Int Med 1980; 93: 244-8.
2. Edmiston CE, Walker AP, Krepel CJ, Gohr C. The nonpuerperal breast infection: aerobic and anaerobic microbial recovery from acute and chronic disease. J Infect Dis 1990; 162: 695-9.
3. Finegold SM. Anaerobic infections in humans: an overview. Anaerobe 1995; 1: 3-9.
4. Giamarellou H, Soulis M, Antoniadou A, Gogas J. Periareolar nonpuerperal breast infection: treatment of 38 cases. Clin Infect Dis 1994; 18: 73-6.
5. Hecht DW. Anaerobes: antibiotic resistance, clinical significance, and the role of susceptibility testing. Anaerobe 2006; 12: 115-21.
6. th edition. Belmont, CA. Star Publishing Company, 2002.
7. Krepel CJ, Gohr CM, Walker AP, Farmer SG, Edmiston CE. Enzymatically active Peptostreptococcus magnus: association with site of infection. J Clin Microbiol 1992; 30: 2330-4.
8. Litterio M, Bianchini H, Carloni G, Di Martino A, Fernández Canigia L, Greco G, et al. Actividad "in vitro" de 10 antimicrobianos frente a bacterias anaerobias. Estudio multicéntrico, 1999-2002. Rev Argent Microbiol 2004; 36: 130-5.
9. Murdoch DA. Gram-positive anaerobic cocci. Clin Microbiol Rev 1998; 11: 81-120.
10. Murdoch DA, Mitchelmore IJ, Tabaqchali S. The clinical importance of gram-positive anaerobic cocci isolated at St Bartholomew's Hospital, London, in 1987. J Med Microbiol 1994; 41: 36-44.
11. Murdoch DA, Shah HN. Reclassification of Peptostreptococcus magnus (Prevot 1933) Holdeman and Moore 1972 as Finegoldia magna comb. nov. and Peptostreptococcus micros (Prevot 1933) Smith 1957 as Micromonas micros comb. nov. Anaerobe 1999; 5: 555-9.
12. Murdoch DA, Shah HN, Gharbia SE, Rajendram D. Proposal to restrict the genus Peptostreptococcus (Kluyver & van Niel 1936) to Peptostreptococcus anaerobius. Anaerobe 2000; 6: 257-60.
13. Rajendram D, Shah HN, Gharbia SE, Murdoch DA. Reclassification of Peptostreptococcus asaccharolyticus (Distaso 1912) Ezaki, Yamamoto, Ninomiya, Suzuki and Yabuuchi 1983 as Schleiferella asaccharolytica comb, nov., Peptostreptococcus indolicus (Christiansen 1934) Ezaki, Yamamoto, Ninomiya, Suzuki and Yabuuchi 1983 as Schleiferella indolica comb, nov., Peptostreptococcus lacrimalis Li, Hashimoto, Adnan, Miura, Yamamoto and Ezaki 1992 as Schleiferella lacrimalis com. nov. and Peptostreptococcus harei (Murdoch, Collins, Willems, Hardie, Young and Magee 1997) as Schleiferella harei comb. nov. Anaerobe 2001; 7: 93-101.
14. Rollet R, Cabrera R, Lehmann E, Costa N, Couto E, Hardie N. Cocos anaerobios gram positivos en materiales clínicos. IV Actividad Científica Anual de la Sociedad Argentina de Bacteriología Clínica, 2006, Resumen edition electrónica 16572, Ciudad Autónoma de Buenos Aires, Argentina.
15. Theron MM, Janse van Rensburg MN, Chalkley LJ. Nitroimidazole resistance genes (nimB) in anaerobic grampositive cocci (previously Peptostreptococcus spp.). J Antimicrob Chemother 2004; 54: 240-2.